Home › Non-Muscle Invasive Bladder Cancer › Illinois › Chicago
Non-Muscle Invasive Bladder Cancer clinical trials in Chicago, IL
6 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
RecruitingPhase 3
- Northwestern University, Chicago
- University of Illinois, Chicago
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
RecruitingPhase 1
- Northwestern Memorial Hospital, Chicago
- Northwestern University - Feinberg School of Medicine, Chicago
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
RecruitingPhase 1/2
- Northwestern University ( Site 0051), Chicago
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RecruitingPhase 1
- The University of Chicago Medical Center (UCMC), Chicago
Blue Light Cystoscopy With Cysview® Registry
RecruitingObservational study
- Northwestern University, Chicago
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
RecruitingPhase 2
- Site 02-012 - University of Chicago, Chicago
Non-Muscle Invasive Bladder Cancer trials in other cities
- Columbus, OH10 studies
- Dallas, TX10 studies
- New York City, NY10 studies
- Myrtle Beach, SC9 studies
- Edison, NJ9 studies
- Baltimore, MD8 studies
- Nashville, TN8 studies
- Syracuse, NY8 studies
- Houston, TX7 studies
- Indianapolis, IN7 studies
- Birmingham, AL7 studies
- Philadelphia, PA7 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer59 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Lung Cancer41 studies
- Obesity41 studies
- Ovarian Cancer36 studies
- Colorectal Cancer34 studies
- Stroke34 studies
- Heart Failure31 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.